Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.05 HKD
−24.42 M HKD
249.01 M HKD
611.96 M
About LEPU BIOPHARMA CO LTD
Sector
CEO
Ziye Sui
Headquarters
Shanghai
Website
Founded
2018
ISIN
CNE100004SM4
FIGI
BBG0158783P1
Lepu Biopharma Co., Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of drugs for cancer targeted therapy and oncology immunotherapy. The company was founded by Zhong Jie Pu on January 19, 2018 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2157 is 3.08 HKD — it has increased by 16.23% in the past 24 hours. Watch LEPU BIOPHARMA CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange LEPU BIOPHARMA CO LTD stocks are traded under the ticker 2157.
2157 stock has risen by 12.41% compared to the previous week, the month change is a −5.81% fall, over the last year LEPU BIOPHARMA CO LTD has showed a −22.42% decrease.
2157 reached its all-time high on Sep 9, 2022 with the price of 31.80 HKD, and its all-time low was 2.16 HKD and was reached on Aug 23, 2024. View more price dynamics on 2157 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2157 stock is 18.66% volatile and has beta coefficient of 1.56. Track LEPU BIOPHARMA CO LTD stock price on the chart and check out the list of the most volatile stocks — is LEPU BIOPHARMA CO LTD there?
Today LEPU BIOPHARMA CO LTD has the market capitalization of 4.53 B, it has increased by 0.75% over the last week.
Yes, you can track LEPU BIOPHARMA CO LTD financials in yearly and quarterly reports right on TradingView.
LEPU BIOPHARMA CO LTD is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
2157 net income for the last half-year is −208.52 M HKD, while the previous report showed 129.43 M HKD of net income which accounts for −261.10% change. Track more LEPU BIOPHARMA CO LTD financial stats to get the full picture.
No, 2157 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 429.00 employees. See our rating of the largest employees — is LEPU BIOPHARMA CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LEPU BIOPHARMA CO LTD EBITDA is −362.09 M HKD, and current EBITDA margin is −128.04%. See more stats in LEPU BIOPHARMA CO LTD financial statements.
Like other stocks, 2157 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LEPU BIOPHARMA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LEPU BIOPHARMA CO LTD technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LEPU BIOPHARMA CO LTD stock shows the sell signal. See more of LEPU BIOPHARMA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.